World's Best Scientists 2026 revealed!
Maria C. Rodriguez-Oroz

Maria C. Rodriguez-Oroz

D-Index & Metrics

Neuroscience

D-Index
66
Citations
25314
World Ranking
2952
National Ranking
42

Best Publications

  • Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines

    Irene Litvan;Jennifer G. Goldman;Alexander I. Tröster;Ben A. Schmand

  • Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up

    M C Rodriguez-Oroz;J A Obeso;A E Lang;J L Houeto

  • Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease

    Peter Redgrave;Manuel Rodriguez;Manuel Rodriguez;Yoland Smith;Yoland Smith;Maria C. Rodriguez-Oroz;Maria C. Rodriguez-Oroz

  • Pathophysiology of the basal ganglia in Parkinson's disease.

    José A. Obeso;Maria C. Rodriguez-Oroz;Manuel Rodriguez;José L. Lanciego

  • Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

    Maria C Rodriguez-Oroz;Maria C Rodriguez-Oroz;Marjan Jahanshahi;Paul Krack;Paul Krack;Irene Litvan

  • Missing pieces in the Parkinson's disease puzzle.

    Jose A Obeso;Maria C Rodriguez-Oroz;Christopher G Goetz;Concepcion Marin;Concepcion Marin

  • MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI

    Irene Litvan;Dag Aarsland;Charles H. Adler;Jennifer G. Goldman

  • Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease

    Jose A. Obeso;Maria Cruz Rodríguez-Oroz;Beatriz Benitez-Temino;Franscisco J. Blesa

  • Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains

    Lydia Alvarez-Erviti;Maria C. Rodriguez-Oroz;J. Mark Cooper;Cristina Caballero

  • The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics

    Maria C. Rodriguez-Oroz;Manuel Rodriguez;Jorge Guridi;Klaus Mewes

  • Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.

    Elena Moro;Andres M. Lozano;Pierre Pollak;Yves Agid

  • The impact of deep brain stimulation on executive function in Parkinson's disease.

    M. Jahanshahi;C. M. A. Ardouin;R. G. Brown;J. C. Rothwell

  • Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.

    M C Rodriguez;J A Obeso;C W Olanow

  • Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

    Matthieu F. Bastide;Wassilios G. Meissner;Barbara Picconi;Stefania Fasano

  • The basal ganglia in Parkinson's disease: Current concepts and unexplained observations

    Jose A. Obeso;Concepcio Marin;C. Rodriguez-Oroz;Javier Blesa

  • Coupling between Beta and High-Frequency Activity in the Human Subthalamic Nucleus May Be a Pathophysiological Mechanism in Parkinson's Disease

    Jon López-Azcárate;Mikel Tainta;María C. Rodríguez-Oroz;Miguel Valencia

  • Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders

    Valerie Voon;Pierre-Olivier Fernagut;Jeff Wickens;Christelle Baunez

  • Deep brain stimulation: postoperative issues.

    Günther Deuschl;Jan Herzog;Galit Kleiner-Fisman;Cynthia Kubu

  • Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor

    Robert E. Gross;Paul Krack;Maria C. Rodriguez-Oroz;Ali R. Rezai

  • Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update.

    Valerie Voon;Valerie Voon;T Celeste Napier;Michael J Frank;Veronique Sgambato-Faure;Veronique Sgambato-Faure

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: